{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:02:33Z","timestamp":1782831753703,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.arteri.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T10:35:47Z","timestamp":1657276547000},"page":"311-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efecto de la administraci\u00f3n de diferentes formas de vitamina D en la presi\u00f3n arterial y rigidez a\u00f3rticas, y su implicaci\u00f3n en la reducci\u00f3n de la albuminuria en la enfermedad renal cr\u00f3nica"],"prefix":"10.1016","volume":"34","author":[{"given":"Almudena","family":"Martin-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jary","family":"Perell\u00f3-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Hidalgo-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Michan-Do\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Bosco L\u00f3pez S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"G\u00f3mez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2022.05.002_bib0220","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jsbmb.2006.12.078","article-title":"Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease","volume":"103","author":"Hewison","year":"2007","journal-title":"J Steroid Biochem Mol Biol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0230","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.arteri.2022.05.002_bib0235","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.01150308","article-title":"Vitamin D and kidney disease","volume":"3","author":"Al-Badr","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.arteri.2022.05.002_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.11.029","article-title":"Pleiotropic effects of vitamin D in chronic kidney disease","volume":"453","author":"Liu","year":"2016","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.arteri.2022.05.002_bib0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: Metabolism, molecular mechanism of action, and pleiotropic effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol Rev."},{"key":"10.1016\/j.arteri.2022.05.002_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nefro.2015.11.003","article-title":"The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism","volume":"36","author":"Egido","year":"2016","journal-title":"Nefrologia."},{"key":"10.1016\/j.arteri.2022.05.002_bib0260","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.168.12.1340","article-title":"Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality","volume":"168","author":"Dobnig","year":"2008","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.arteri.2022.05.002_bib0265","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2215\/CJN.00910113","article-title":"25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system","volume":"8","author":"Fern\u00e1ndez-Ju\u00e1rez","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0270","doi-asserted-by":"crossref","first-page":"e91363","DOI":"10.1371\/journal.pone.0091363","article-title":"Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients","volume":"9","author":"Chitalia","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.arteri.2022.05.002_bib0275","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0280","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0285","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.hjc.2017.12.010","article-title":"Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism","volume":"60","author":"Giakoumis","year":"2019","journal-title":"Hellenic J Cardiol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0290","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: A randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.arteri.2022.05.002_bib0295","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial","volume":"376","author":"De Zeeuw","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2022.05.002_bib0300","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-\u03b21 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.arteri.2022.05.002_bib0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ndt\/gft360","article-title":"The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: A prospective controlled study","volume":"29","author":"Molina","year":"2014","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.arteri.2022.05.002_bib0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2369-14-163","article-title":"Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: A randomized placebo-controlled trial","volume":"14","author":"Larsen","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0315","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1681\/ASN.2016040407","article-title":"Effects of vitamin D receptor activation and dietary sodium restriction on residual albuminuria in CKD: The ViRTUE-CKD Trial","volume":"28","author":"Keyzer","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0320","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ajkd.2018.04.005","article-title":"Arterial stiffness in CKD: A review","volume":"73","author":"Townsend","year":"2019","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.arteri.2022.05.002_bib0325","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1681\/ASN.2006111217","article-title":"Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: The Hoorn Study","volume":"18","author":"Hermans","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0330","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1-201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"10.1016\/j.arteri.2022.05.002_bib0335","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2022.05.002_bib0340","article-title":"Role of increased central arterial stiffness in macro and microvascular damage in patients with coronary artery disease","author":"Hidalgo-Santiago","year":"2021","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2022.05.002_bib0345","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(97)00106-8","article-title":"New indice to classify location, severity and progression of calcific lesions in the abdominal aorta: A 2-year follow-up study","volume":"132","author":"Kauppila","year":"1997","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2022.05.002_bib0350","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.2215\/CJN.01670211","article-title":"Hemodynamic correlates of proteinuria in chronic kidney disease","volume":"6","author":"Weir","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0355","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/ki.2010.387","article-title":"New vitamin D analogs and changing therapeutic paradigms","volume":"79","author":"Cunningham","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.arteri.2022.05.002_bib0360","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1523-1755.2003.00114.x","article-title":"Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats","volume":"64","author":"Takemoto","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.arteri.2022.05.002_bib0365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","article-title":"Megalin and cubilin in proximal tubule protein reabsorption: From experimental models to human disease","volume":"89","author":"Nielsen","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.arteri.2022.05.002_bib0370","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydro-xyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J Biol Chem."},{"key":"10.1016\/j.arteri.2022.05.002_bib0375","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/nu12020575","article-title":"Vitamin D and endothelial function","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients."},{"key":"10.1016\/j.arteri.2022.05.002_bib0380","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/15701611113119990028","article-title":"Clinical uses of 1,25-dihydroxy-19-nor-vitamin D(2) (paricalcitol)","volume":"12","author":"Bover","year":"2014","journal-title":"Curr Vasc Pharmacol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0385","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00684.2011","article-title":"In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt\/\u03b2-catenin activation","volume":"303","author":"Mart\u00ednez-Moreno","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0390","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nefro.2019.08.001","article-title":"Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patiente Far beyond mineral bone disease regulation","volume":"40","author":"Salanova Villanueva","year":"2020","journal-title":"Nefrologia."},{"key":"10.1016\/j.arteri.2022.05.002_bib0395","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000441364","article-title":"Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: A randomized trial","volume":"42","author":"Lundwall","year":"2015","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0400","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: A systematic review","volume":"24","author":"De Borst","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0405","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc20-1622","article-title":"Changes in albuminuria predict cardiovascular and renal outcomes in type 2 diabetes: A post hoc analysis of the LEADER trial","volume":"44","author":"Persson","year":"2021","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2022.05.002_bib0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/157339911794273964","article-title":"Podocytes as target of vitamin D","volume":"7","author":"Li","year":"2011","journal-title":"Curr Diabetes Rev."},{"key":"10.1016\/j.arteri.2022.05.002_bib0415","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/ndt\/gfaa373","article-title":"Effects of calcitriol and paricalcitol on renal fibrosis in CKD","volume":"36","author":"Mart\u00ednez-Arias","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.arteri.2022.05.002_bib0420","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000499187","article-title":"Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease","volume":"49","author":"Strugnell","year":"2019","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.arteri.2022.05.002_bib0425","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ki.2012.311","article-title":"Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease","volume":"83","author":"De Boer","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.arteri.2022.05.002_bib0430","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2017;7:1-59. DOI 10.1016\/j.kisu. 2017.04.001.","DOI":"10.1016\/j.kisu.2017.10.001"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916822000572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916822000572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:32:53Z","timestamp":1759325573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916822000572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0214916822000572"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2022.05.002","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efecto de la administraci\u00f3n de diferentes formas de vitamina D en la presi\u00f3n arterial y rigidez a\u00f3rticas, y su implicaci\u00f3n en la reducci\u00f3n de la albuminuria en la enfermedad renal cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}